Karyopharm Therapeutics (KPTI)

• Market cap: $54M
• 1 day: 4.56%
• 5 days: -5.73%
• 1 month: -28.51%
• 3 months: -30.52%
• 6 months: -38.68%
• Year to date: -47.25%
• 1 year: -69.86%
• 5 years: -97.66%
• 10 years: -98.61%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

317% more call options, than puts

Call options by funds: $196K | Put options by funds: $47K

0.49% less ownership

Funds ownership: 48.76% [Q3] → 48.27% (-0.49%) [Q4]

9% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 23

4% less funds holding

Funds holding: 90 [Q3] → 86 (-4) [Q4]

18% less capital invested

Capital invested by funds: $50.4M [Q3] → $41.2M (-$9.17M) [Q4]

22% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 18

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $45 601% upside
• Avg. target: $52 705% upside
• High target: $56 772% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Baird Michael Ulz 22% 1-year accuracy 4 / 18 met price target	741% upside $54	Outperform Maintained	3 Mar 2025
HC Wainwright & Co. Edward White 28% 1-year accuracy 40 / 143 met price target	772% upside $56	Buy Maintained	26 Feb 2025
RBC Capital Brian Abrahams 17% 1-year accuracy 12 / 72 met price target	601% upside $45	Outperform Reiterated	20 Feb 2025